KATIE WHITE: Open Payments
NPI 1386089357 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 124 payments from 18 companies in 2025. Trend: 2023 $2,667 · 2024 $2,946 · 2025 $2,619
Food & beverage: $2,619
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $327 |
| GENZYME CORPORATION | 9 | $312 |
| Regeneron Healthcare Solutions, Inc. | 8 | $259 |
| ABBVIE INC. | 14 | $246 |
| Galderma Laboratories, L.P. | 9 | $235 |
| Arcutis Biotherapeutics, Inc. | 16 | $199 |
| Novartis Pharmaceuticals Corporation | 10 | $184 |
| Janssen Biotech, Inc. | 7 | $164 |
| PFIZER INC. | 15 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $141 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, Zoryve, COSENTYX, TREMFYA, CIBINQO, Winlevi.
Industry payments across OK — which companies pay providers there.
